These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16539721

  • 1. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
    Goffinet M, Thoulouzan M, Pradines A, Lajoie-Mazenc I, Weinbaum C, Faye JC, Séronie-Vivien S.
    BMC Cancer; 2006 Mar 15; 6():60. PubMed ID: 16539721
    [Abstract] [Full Text] [Related]

  • 2. Anticancer effects of zoledronic acid against human osteosarcoma cells.
    Kubista B, Trieb K, Sevelda F, Toma C, Arrich F, Heffeter P, Elbling L, Sutterlüty H, Scotlandi K, Kotz R, Micksche M, Berger W.
    J Orthop Res; 2006 Jun 15; 24(6):1145-52. PubMed ID: 16602111
    [Abstract] [Full Text] [Related]

  • 3. The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro.
    Mitrofan LM, Pelkonen J, Mönkkönen J.
    Bone; 2009 Dec 15; 45(6):1153-60. PubMed ID: 19699819
    [Abstract] [Full Text] [Related]

  • 4. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM, Senaratne SG, Clarke IA, Kirby RS, Colston KW.
    J Urol; 2003 Jul 15; 170(1):246-52. PubMed ID: 12796698
    [Abstract] [Full Text] [Related]

  • 5. Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation.
    Yamada J, Tsuno NH, Kitayama J, Tsuchiya T, Yoneyama S, Asakage M, Okaji Y, Shuno Y, Nishikawa T, Tanaka J, Takahashi K, Nagawa H.
    J Surg Res; 2009 Jan 15; 151(1):115-20. PubMed ID: 18619615
    [Abstract] [Full Text] [Related]

  • 6. Zoledronic acid, an aminobisphosphonate, modulates differentiation and maturation of human dendritic cells.
    Chen YJ, Chao KS, Yang YC, Hsu ML, Lin CP, Chen YY.
    Immunopharmacol Immunotoxicol; 2009 Jan 15; 31(3):499-508. PubMed ID: 19555208
    [Abstract] [Full Text] [Related]

  • 7. Zoledronic acid, a third-generation bisphosphonate, inhibits cellular growth and induces apoptosis in oral carcinoma cell lines.
    Tamura T, Shomori K, Nakabayashi M, Fujii N, Ryoke K, Ito H.
    Oncol Rep; 2011 Apr 15; 25(4):1139-43. PubMed ID: 21249320
    [Abstract] [Full Text] [Related]

  • 8. Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
    Tanaka T, Kawashima H, Ohnishi K, Matsumura K, Yoshimura R, Matsuyama M, Kuratsukuri K, Nakatani T.
    Anticancer Res; 2009 Apr 15; 29(4):1089-94. PubMed ID: 19414350
    [Abstract] [Full Text] [Related]

  • 9. Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
    Räikkönen J, Mönkkönen H, Auriola S, Mönkkönen J.
    Biochem Pharmacol; 2010 Mar 01; 79(5):777-83. PubMed ID: 19819230
    [Abstract] [Full Text] [Related]

  • 10. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 01; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 11. Zoledronic acid: an unending tale for an antiresorptive agent.
    Caraglia M, Marra M, Naviglio S, Botti G, Addeo R, Abbruzzese A.
    Expert Opin Pharmacother; 2010 Jan 01; 11(1):141-54. PubMed ID: 20001436
    [Abstract] [Full Text] [Related]

  • 12. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Virtanen SS, Väänänen HK, Härkönen PL, Lakkakorpi PT.
    Cancer Res; 2002 May 01; 62(9):2708-14. PubMed ID: 11980672
    [Abstract] [Full Text] [Related]

  • 13. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation.
    Coxon JP, Oades GM, Kirby RS, Colston KW.
    BJU Int; 2004 Jul 01; 94(1):164-70. PubMed ID: 15217454
    [Abstract] [Full Text] [Related]

  • 14. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
    Jagdev SP, Coleman RE, Shipman CM, Rostami-H A, Croucher PI.
    Br J Cancer; 2001 Apr 20; 84(8):1126-34. PubMed ID: 11308265
    [Abstract] [Full Text] [Related]

  • 15. Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer.
    Hashimoto K, Masumori N, Tanaka T, Maeda T, Kobayashi K, Kitamura H, Hirata K, Tsukamoto T.
    Prostate; 2013 Apr 20; 73(5):500-11. PubMed ID: 22996996
    [Abstract] [Full Text] [Related]

  • 16. Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells.
    Iguchi K, Tatsuda Y, Usui S, Hirano K.
    Eur J Pharmacol; 2010 Sep 01; 641(1):35-40. PubMed ID: 20519142
    [Abstract] [Full Text] [Related]

  • 17. Zoledronic acid activates the DNA S-phase checkpoint and induces osteosarcoma cell death characterized by apoptosis-inducing factor and endonuclease-G translocation independently of p53 and retinoblastoma status.
    Ory B, Blanchard F, Battaglia S, Gouin F, Rédini F, Heymann D.
    Mol Pharmacol; 2007 Jan 01; 71(1):333-43. PubMed ID: 17050806
    [Abstract] [Full Text] [Related]

  • 18. Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells.
    Koizumi M, Nakaseko C, Ohwada C, Takeuchi M, Ozawa S, Shimizu N, Cho R, Nishimura M, Saito Y.
    Eur J Haematol; 2007 Nov 01; 79(5):382-91. PubMed ID: 17903213
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines.
    Matsumoto S, Kimura S, Segawa H, Kuroda J, Yuasa T, Sato K, Nogawa M, Tanaka F, Maekawa T, Wada H.
    Lung Cancer; 2005 Jan 01; 47(1):31-9. PubMed ID: 15603852
    [Abstract] [Full Text] [Related]

  • 20. Zoledronic acid mediates Ras-independent growth inhibition of prostate cancer cells.
    Nogawa M, Yuasa T, Kimura S, Kuroda J, Segawa H, Sato K, Yokota A, Koizumi M, Maekawa T.
    Oncol Res; 2005 Jan 01; 15(1):1-9. PubMed ID: 15839301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.